• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌中肝脏再生的微环境

Microenvironment of liver regeneration in liver cancer.

作者信息

Li Han-Min, Ye Zhi-Hua

机构信息

Institute of Application Foundation and Institute of Liver Diseases, Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430061, China.

Hubei Province Academy of Traditional Chinese Medicine, Wuhan, 430074, China.

出版信息

Chin J Integr Med. 2017 Jul;23(7):555-560. doi: 10.1007/s11655-017-2806-0. Epub 2017 May 18.

DOI:10.1007/s11655-017-2806-0
PMID:28523536
Abstract

The occurrence and development of liver cancer are essentially the most serious outcomes of uncontrolled liver regeneration. The progression of liver cancer is inevitably related to the abnormal microenvironment of liver regeneration. The deterioration observed in the microenvironment of liver regeneration is a necessary condition for the occurrence, development and metastasis of cancer. Therefore, the use of a technique to prevent and treat liver cancer via changes in the microenvironment of liver regeneration is a novel strategy. This strategy would be an effective way to delay, prevent or even reverse cancer occurrence, development and metastasis through an improvement in the liver regeneration microenvironment along with the integrated regulation of multiple components, targets, levels, channels and time sequences. In addition, the treatment of "tonifying Shen (Kidney) to regulate liver regeneration and repair by affecting stem cells and their microenvironment" can regulate "the dynamic imbalance between the normal liver regeneration and the abnormal liver regeneration"; this would improve the microenvironment of liver regeneration, which is also a mechanism by which liver cancer may be prevented or treated.

摘要

肝癌的发生发展本质上是肝脏再生失控的最严重后果。肝癌的进展不可避免地与肝脏再生的异常微环境相关。肝脏再生微环境中观察到的恶化是癌症发生、发展和转移的必要条件。因此,通过改变肝脏再生微环境来防治肝癌的技术是一种新策略。该策略将是一种有效的方法,通过改善肝脏再生微环境以及对多个成分、靶点、水平、途径和时间序列的综合调控,来延缓、预防甚至逆转癌症的发生、发展和转移。此外,“补肾调肝,从干细胞及其微环境论治肝再生修复”可调控“正常肝再生与异常肝再生之间的动态失衡”;这将改善肝脏再生微环境,这也是预防或治疗肝癌的一种机制。

相似文献

1
Microenvironment of liver regeneration in liver cancer.肝癌中肝脏再生的微环境
Chin J Integr Med. 2017 Jul;23(7):555-560. doi: 10.1007/s11655-017-2806-0. Epub 2017 May 18.
2
Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine.肝癌的微循环、肝再生的微环境与中医策略
Chin J Integr Med. 2016 Mar;22(3):163-7. doi: 10.1007/s11655-016-2460-y. Epub 2016 Feb 27.
3
Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy.用于预防和治疗的肝细胞癌肝再生微环境
Oncotarget. 2017 Jan 3;8(1):1805-1813. doi: 10.18632/oncotarget.12101.
4
Clinical trial with traditional Chinese medicine intervention ''tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment'' for chronic hepatitis B-associated liver failure.中药干预“补肾通过影响干细胞及其微环境促进肝再生与修复”治疗慢性乙型肝炎相关肝衰竭的临床试验
World J Gastroenterol. 2014 Dec 28;20(48):18458-65. doi: 10.3748/wjg.v20.i48.18458.
5
Molecular Mechanism of Bushen Jianpi Inhibition of Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma.补肾健脾法防治肝癌术后复发转移的分子机制。
J Biomed Nanotechnol. 2021 Jan 1;17(1):53-63. doi: 10.1166/jbn.2021.3018.
6
Research Progress in Liver-Regenerating Microenvironment and DNA Methylation in Hepatocellular Carcinoma: The Role of Traditional Chinese Medicine.肝细胞癌中肝脏再生微环境与DNA甲基化的研究进展:中医药的作用
Med Sci Monit. 2020 Mar 7;26:e920310. doi: 10.12659/MSM.920310.
7
Effect of liver regeneration on malignant hepatic tumors.肝再生对恶性肝肿瘤的影响。
World J Gastroenterol. 2014 Nov 21;20(43):16167-77. doi: 10.3748/wjg.v20.i43.16167.
8
[New thoughts are needed for the study of liver cancer recurrence and metastasis].肝癌复发与转移的研究需要新的思路。
Zhonghua Gan Zang Bing Za Zhi. 2016 May 20;24(5):321-3. doi: 10.3760/cma.j.issn.1007-3418.2016.05.001.
9
[An optimized 3-step strategy for preventing and treating post-operation relapse and metastasis of malignant tumors with traditional Chinese medicine].[一种运用中医药防治恶性肿瘤术后复发转移的优化三步策略]
Zhong Xi Yi Jie He Xue Bao. 2007 Jan;5(1):5-10.
10
Road to stemness in hepatocellular carcinoma.肝癌干性的发生通路。
World J Gastroenterol. 2017 Oct 7;23(37):6750-6776. doi: 10.3748/wjg.v23.i37.6750.

引用本文的文献

1
Effects of the support system combined with Chinese medicine on postoperative gastrointestinal recovery in patients with liver cancer.支持系统联合中药对肝癌患者术后胃肠道恢复的影响
World J Gastrointest Oncol. 2025 Aug 15;17(8):105267. doi: 10.4251/wjgo.v17.i8.105267.
2
HMGB1/TREM1 crosstalk between heat-injured hepatocytes and macrophages promotes HCC progression after RFA.热损伤的肝细胞和巨噬细胞之间的 HMGB1/TREM1 串扰促进了 RFA 后的 HCC 进展。
J Cancer Res Clin Oncol. 2024 Oct 28;150(10):480. doi: 10.1007/s00432-024-05996-9.
3
Constructing a prognostic model for hepatocellular carcinoma based on bioinformatics analysis of inflammation-related genes.

本文引用的文献

1
Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy.用于预防和治疗的肝细胞癌肝再生微环境
Oncotarget. 2017 Jan 3;8(1):1805-1813. doi: 10.18632/oncotarget.12101.
2
Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine.肝癌的微循环、肝再生的微环境与中医策略
Chin J Integr Med. 2016 Mar;22(3):163-7. doi: 10.1007/s11655-016-2460-y. Epub 2016 Feb 27.
3
Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection.
基于炎症相关基因的生物信息学分析构建肝细胞癌预后模型
Front Med (Lausanne). 2024 Jul 11;11:1420353. doi: 10.3389/fmed.2024.1420353. eCollection 2024.
4
The Indispensable Roles of GMDS and GMDS-AS1 in the Advancement of Cancer: Fucosylation, Signal Pathway and Molecular Pathogenesis.GMDS 和 GMDS-AS1 在癌症进展中的不可或缺作用:岩藻糖基化、信号通路和分子发病机制。
Mini Rev Med Chem. 2024;24(19):1712-1722. doi: 10.2174/0113895575285276240324080234.
5
USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.USP14 在肝细胞癌中表达水平较高,通过 HK2/AKT/P62 轴发挥关键作用,促进肝癌细胞的生长。
BMC Cancer. 2024 Feb 21;24(1):237. doi: 10.1186/s12885-024-12009-y.
6
Photothermal Fibrous Chitosan/Polydopamine Sponge for Intraoperative Hemostasis and Prevention of Tumor Recurrence in Hepatocellular Carcinoma Resection.光热纤维壳聚糖/聚多巴胺海绵在肝细胞癌切除术中的止血和预防肿瘤复发的应用
Adv Sci (Weinh). 2024 Jan;11(3):e2304053. doi: 10.1002/advs.202304053. Epub 2023 Nov 29.
7
Epigenetic inhibition of lncRNA GMDS-AS1 by methyltransferase ESET promoted cell viability and metastasis of hepatocellular carcinoma.甲基转移酶 ESET 通过抑制长链非编码 RNA GMDS-AS1 的表观遗传来促进肝癌细胞的活力和转移。
Clin Transl Oncol. 2023 Jun;25(6):1793-1804. doi: 10.1007/s12094-023-03077-w. Epub 2023 Feb 3.
8
Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinoma.与老年肝细胞癌患者预后相关的围手术期因素。
Eur J Med Res. 2022 Dec 9;27(1):280. doi: 10.1186/s40001-022-00896-5.
9
Lipid Profiles Obtained from MALDI Mass Spectrometric Imaging in Liver Cancer Metastasis Model.从肝癌转移模型的基质辅助激光解吸电离质谱成像获得的脂质谱。
Int J Anal Chem. 2022 Oct 27;2022:6007158. doi: 10.1155/2022/6007158. eCollection 2022.
10
Effect of perioperative factors on the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.围手术期因素对接受肝切除术的肝细胞癌患者预后的影响。
Turk J Med Sci. 2022 Aug;52(4):1067-1074. doi: 10.55730/1300-0144.5409. Epub 2022 Aug 10.
早期肝细胞癌侵袭性的预测,以选择手术切除。
J Hepatol. 2014 Jun;60(6):1219-24. doi: 10.1016/j.jhep.2014.01.027. Epub 2014 Feb 15.
4
Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion.外显子 70 异构体在上皮-间质转化过程中的转换介导癌细胞侵袭。
Dev Cell. 2013 Dec 9;27(5):560-73. doi: 10.1016/j.devcel.2013.10.020.
5
The epigenetics of epithelial-mesenchymal plasticity in cancer.癌症中上皮-间充质可塑性的表观遗传学。
Nat Med. 2013 Nov;19(11):1438-49. doi: 10.1038/nm.3336. Epub 2013 Nov 7.
6
Epithelial plasticity: a common theme in embryonic and cancer cells.上皮细胞可塑性:胚胎细胞和癌细胞中的共同主题。
Science. 2013 Nov 8;342(6159):1234850. doi: 10.1126/science.1234850.
7
Evidence for and against epithelial-to-mesenchymal transition in the liver.肝内上皮-间充质转化的证据及争议。
Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G881-90. doi: 10.1152/ajpgi.00289.2013. Epub 2013 Oct 24.
8
Met as a therapeutic target in HCC: facts and hopes.作为 HCC 的治疗靶点:现状与展望。
J Hepatol. 2014 Feb;60(2):442-52. doi: 10.1016/j.jhep.2013.09.009. Epub 2013 Sep 14.
9
HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.肝细胞癌中 HGF-MET 信号通过 MLL-ETS2 复合物传递。
J Clin Invest. 2013 Jul;123(7):3154-65. doi: 10.1172/JCI65566. Epub 2013 Jun 24.
10
Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.载脂蛋白 L2 通过表皮生长因子(TGF-β1)/Lcn2/Twist1 通路负向调控肝癌细胞上皮间质转化。
Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.